TWD 15.1
(-1.63%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 138.87 Million TWD | 25.47% |
2022 | 205.14 Million TWD | 12.72% |
2021 | 181.99 Million TWD | 0.49% |
2020 | 181.1 Million TWD | 17.85% |
2019 | 153.67 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 65.37 Million TWD | 0.0% |
2024 Q1 | 65.37 Million TWD | -11.44% |
2023 Q3 | 73.82 Million TWD | 20.84% |
2023 FY | 257.38 Million TWD | 25.47% |
2023 Q2 | 61.09 Million TWD | 0.0% |
2023 Q1 | 61.09 Million TWD | 16.85% |
2023 Q4 | 73.82 Million TWD | 0.0% |
2022 FY | 205.14 Million TWD | 12.72% |
2022 Q4 | 52.28 Million TWD | 0.0% |
2022 Q3 | 52.28 Million TWD | 0.0% |
2021 FY | 181.99 Million TWD | 0.49% |
2020 FY | 181.1 Million TWD | 17.85% |
2019 FY | 153.67 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -8.773% |
Level Biotechnology Inc. | 151.99 Million TWD | 8.634% |
Sagittarius Life Science Corp | 135.85 Million TWD | -2.221% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -83.063% |
TaiMed Biologics Inc. | 225.23 Million TWD | 38.344% |
GlycoNex Incorporation | 995 Thousand TWD | -13856.784% |
VBI | 32.55 Million TWD | -326.57% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 45.937% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 28.486% |
Visgeneer Inc. | 67.48 Million TWD | -105.788% |
Mycenax Biotech Inc. | -375.19 Million TWD | 137.013% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 72.776% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -117.314% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 90.383% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -373.119% |
Enimmune corporation | 220.1 Million TWD | 36.907% |
TaiRx, Inc. | 217.13 Million TWD | 36.044% |
CHO Pharma, Inc. | 268.99 Million TWD | 48.375% |
EirGenix Inc. | 236.74 Million TWD | 41.341% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -33.08% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 61.168% |
Lin BioScience, Inc. | 1.09 Billion TWD | 87.339% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 47.824% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -180.71% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -12722.715% |
Lukas Biomedical Inc. | 177.45 Million TWD | 21.741% |
RBC Bioscience Corporation | 58.35 Million TWD | -137.97% |
BiOptic Inc. | 108.69 Million TWD | -27.765% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -154200.0% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -100.245% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -5210.516% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 78.434% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -42109.726% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -201.74% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -15.812% |
Neith Corporation | 66.87 Million TWD | -107.662% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -48.785% |
NaviFUS Corp. | 11.82 Million TWD | -1074.178% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 27.19% |
Sinew Pharma Inc. | 186.25 Million TWD | 25.44% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -87.604% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 36.991% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -234.78% |
AP Biosciences Inc | 32.25 Million TWD | -330.565% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 92.495% |
3D Global Biotech Inc. | 5.27 Million TWD | -2533.106% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 56.237% |
Intech Biopharm Corporation | -163.99 Million TWD | 184.679% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 87.702% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -234.772% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 18.098% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 5.545% |
TCI GENE Inc. | 174.61 Million TWD | 20.472% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -771400.0% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 53.854% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 52.271% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -65.43% |
PharmaEngine, Inc. | 441.78 Million TWD | 68.566% |
Savior Lifetec Corporation | 223.36 Million TWD | 37.829% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 46.336% |
OBI Pharma, Inc. | 2.01 Billion TWD | 93.113% |
Acepodia, Inc. | 452.56 Million TWD | 69.315% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 74.328% |